Clinical phenotype and genetic analysis of a patient with Oocyte maturation defect due to a novel variant of PATL2 gene.
10.3760/cma.j.cn511374-20250121-00043
- Author:
Fangzhu WANG
1
,
2
;
Yali NI
;
Lin ZHANG
;
Bo YAN
;
Jinwei YANG
;
Chuan ZHANG
;
Zhiqiang WANG
Author Information
1. Center of Reproductive Medicine, Gansu Provincial Maternal and Child Health Care Hospital (Gansu Provincial Central Hospital), Lanzhou, Gansu 730050, China. babaral_w@
2. com.
- Publication Type:English Abstract
- MeSH:
Female;
Humans;
Young Adult;
Exome Sequencing;
Infertility, Female/genetics*;
Oocytes/metabolism*;
Pedigree;
Phenotype
- From:
Chinese Journal of Medical Genetics
2025;42(10):1244-1251
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the clinical phenotype and genetic etiology of a patient with primary infertility accompanied by Oocyte maturation defect (OOMD).
METHODS:A 24-year-old female patient who visited the Reproductive Medicine Center of Gansu Provincial Maternity and Child Care Hospital in April 2024 was selected as the study subject. Whole-exome sequencing (WES) was performed on the proband and her husband. Candidate gene variants were validated in the family using Sanger sequencing, and compound heterozygous variants were confirmed through vector construction. Candidate variants were classified for pathogenicity according to the "Standards and Guidelines for the Interpretation of Sequence Variants" established by the American College of Medical Genetics and Genomics (ACMG). This study was approved by the Medical Ethics Committee of the Hospital [Ethics No.: (2023) GSFYLS(78)].
RESULTS:The proband, a 24-year-old female, had been unable to conceive for four years without contraception after marriage. She had undergone two ovarian stimulation cycles using the antagonist protocol and the PPOS protocol, respectively. A total of 74 oocytes were retrieved, with all showing OOMD and some oocytes exhibiting abnormal morphology and poor quality. WES results revealed two heterozygous missense variants in exons 14 and 16 of the PATL2 gene: c.1127G>A (p.R376Q) and c.1388C>G (p.A463G). Family validation results indicated that the missense variant in exon 14 was inherited from the proband's father, while the variant in exon 16 was de novo.
CONCLUSION:The compound heterozygous variants of the PATL2 gene probably underlay the OOMD and infertility in this proband. Further analysis based on the variant sites and protein structures is needed to determine whether PATL2 gene variants can fully affect oocyte development, thereby providing a personalized treatment plan for the proband.
